GGrantIndex
← Search

ESTROGEN MODULATION ON CHOLINERGIC FUNCTION IN POST MENOPAUSAL WOMEN

$32,903M01FY2000RRNIH

University Of Vermont &St Agric College, Burlington VT

Investigators

Linked publications, trials & patents

Abstract

EST treatment for 3 months in PMW will blunt or decrease the cognition-impairing & behavior-disrupting effects of acute administration of the cholinergic antagonists scopolamine and mecamylamine. This effect will be greater on cognitive tasks that are gender-linked.

View original record on NIH RePORTER →